Eyal Sandach
Gründer bei InnovaGraft Biologics LLC
Profil
Mr. Eyal Sandach is Global Chief Operating Officer & General Manager at Medical Compression Systems (DBN) Ltd.
and Partner at InnovaGraft Biologics LLC.
Mr. Sandach was previously employed as a Director-Operations, Program, Sales & Marketing by American Medical Systems Holdings, Inc., Chief Executive Officer by B-Balloon Ltd., Chief Executive Officer by Innovea Medical Ltd., Chief Executive Officer by POP Medical Solutions Ltd., Executive Vice President & General Manager by Neovasc, Inc., Executive Vice President & General Manager by Neovasc Medical Ltd., and General Manager by Medical Ventures Corp.
He received his undergraduate degree from the University of St. Thomas (Minnesota), an undergraduate degree from the Shenkar College of Engineering & Design, and an MBA from the University of St. Thomas (Minnesota).
Aktive Positionen von Eyal Sandach
| Unternehmen | Position | Beginn |
|---|---|---|
| InnovaGraft Biologics LLC | Gründer | 21.10.2009 |
Ehemalige bekannte Positionen von Eyal Sandach
| Unternehmen | Position | Ende |
|---|---|---|
B-Balloon Ltd.
 B-Balloon Ltd. Medical SpecialtiesHealth Technology B-Balloon Ltd. develops devices used to treat ostial and bifurcation lesions in coronary and peripheral arteries. The company is based in Or Yehuda, Israel. B-Balloon was acquired by Medical Ventures Corp. from Peregrine Ventures Management Ltd. on July 02, 2008 for $27.17 million. | Präsident | - |
Astora Women's Health, Inc.
 Astora Women's Health, Inc. Medical SpecialtiesHealth Technology Astora Women's Health, Inc. engages in the provision of pelvic health solutions. The company was founded by Dr. Brantley Scott in 1972 and is headquartered in Minnetonka, MN. | Geschäftsführer | 01.01.2006 |
| PHARMOCANN GLOBAL LTD | Geschäftsführer | - |
Neovasc Medical Ltd.
 Neovasc Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Neovasc Medical Ltd. develops medical devices for the treatment of refractory angina. It offers minimally invasive treatment for Ischemic heart disease. The company was founded in 2002 by Boaz Lifschitz and is headquartered in Or Yehuda, Israel | Corporate Officer/Principal | - |
Medical Ventures Corp.
 Medical Ventures Corp. Electronic Equipment/InstrumentsElectronic Technology Medical Ventures Corp. develops, manufactures and distributes medical devices and is focused on the development and commercialization of medical devices which clearly address a clinical need in the cardiovascular marketplace. The Company has two divisions: PMD tissue products used in cardiac reconstruction and repair and Angiometrx catheter products for the rapidly growing interventional cardiology market. The focus in both divisions is the commercialization of the cardiovascular medical devices currently in the MEV’s product portfolio and the development of new products based upon these two core technologies. The company is located in Richmond, Canada. | Corporate Officer/Principal | - |
Ausbildung von Eyal Sandach
| University of St. Thomas | Masters Business Admin |
| Shenkar College of Engineering & Design | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHARMOCANN GLOBAL LTD | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Astora Women's Health, Inc.
Astora Women's Health, Inc. Medical SpecialtiesHealth Technology Astora Women's Health, Inc. engages in the provision of pelvic health solutions. The company was founded by Dr. Brantley Scott in 1972 and is headquartered in Minnetonka, MN. | Health Technology |
Medical Ventures Corp.
Medical Ventures Corp. Electronic Equipment/InstrumentsElectronic Technology Medical Ventures Corp. develops, manufactures and distributes medical devices and is focused on the development and commercialization of medical devices which clearly address a clinical need in the cardiovascular marketplace. The Company has two divisions: PMD tissue products used in cardiac reconstruction and repair and Angiometrx catheter products for the rapidly growing interventional cardiology market. The focus in both divisions is the commercialization of the cardiovascular medical devices currently in the MEV’s product portfolio and the development of new products based upon these two core technologies. The company is located in Richmond, Canada. | Electronic Technology |
Neovasc, Inc.
 Neovasc, Inc. Medical SpecialtiesHealth Technology Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada. | Health Technology |
Innovea Medical Ltd.
 Innovea Medical Ltd. Medical SpecialtiesHealth Technology Innovea Medical Ltd. develops software solutions for medical images, empower radiologists, and cardiologists. The firm’s flagship product Lumine integrates within the radiologist's workstation to enhance the conspicuity of blood vessels in low-attenuation CT images. The company was founded in 2006 by Adi Mashiach and is headquartered in Ramat Gan, Israel. | Health Technology |
| InnovaGraft Biologics LLC | |
B-Balloon Ltd.
B-Balloon Ltd. Medical SpecialtiesHealth Technology B-Balloon Ltd. develops devices used to treat ostial and bifurcation lesions in coronary and peripheral arteries. The company is based in Or Yehuda, Israel. B-Balloon was acquired by Medical Ventures Corp. from Peregrine Ventures Management Ltd. on July 02, 2008 for $27.17 million. | Health Technology |
Neovasc Medical Ltd.
Neovasc Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Neovasc Medical Ltd. develops medical devices for the treatment of refractory angina. It offers minimally invasive treatment for Ischemic heart disease. The company was founded in 2002 by Boaz Lifschitz and is headquartered in Or Yehuda, Israel | Electronic Technology |
FEMSelect Ltd.
 FEMSelect Ltd. Medical SpecialtiesHealth Technology FEMSelect Ltd. develops solution for treatment of pelvic organ prolapse repair. Its products NeuGuide is an anchoring system for the treatment of uterine prolapse. The company was founded by Eyal Sandach, Menahem Neuman and Boaz Harari in 2010 and is headquartered in Ramat Hachayal, Israel. | Health Technology |
